U040 Male Genital Dermatology
DESCRIPTION
Male genital skin diseases are responsible for significant sexual and urological morbidity. This session comprehensively addresses the pathogenesis, diagnosis and management of the principal dermatoses and some important rarities. The common inflammatory conditions (eczema, psoriasis, lichen planus) and some important rarities (penile oedema/cellulitis, extramammary Paget disease) are discussed but the emphasis is on lichen sclerosus and penile intraepithelial neoplasia
LEARNING OBJECTIVES
Diagnose and treat common important and rare male genital skin diseases more effectively
Discuss the pathogenesis, management and prognosis of lichen sclerous and penile intraepithelial neoplasia
Perform and utilize male genital genital skin biopsy appropriately
SCHEDULE
4:30 PM
Common male genital dermatoses
Richard Watchorn, MBBCh
4:40 PM
Male genital lichen sclerosus
Christopher Barry Bunker, MD, IFAAD
4:55 PM
Penile intraepithelial neoplasia and extramammary Pagets disease
Georgios Kravvas, MBBS
5:10 PM
Penis biopsy
5:20 PM
Penile oedema and cellulitis
Philip R. Doiron, MD, FAAD
DIRECTOR
Christopher Barry Bunker, MD, IFAAD
University College Hospitals/University College, London, UK
SPEAKERS
Philip R. Doiron, MD, FAAD
University of Toronto
Georgios Kravvas, MBBS
Department of Dermatology, University College London Hospitals, London, UK
Richard Watchorn, MBBCh
DISCLOSURES
Christopher Barry Bunker, MD, IFAAD
American Academy of Dermatology – Speaker(No Compensation Received); American Dermatological Association – Speaker(No Compensation Received); British Association of Dermatologists – Advisory Board(No Compensation Received), Speaker(No Compensation Received); British Skin Foundation – Board of Directors(No Compensation Received), Investigator(No Compensation Received); European Academy of Dermatology and Venereology – Speaker(No Compensation Received); European Dermatology Forum – Other(No Compensation Received); International Society of Dermatology – Board of Directors(No Compensation Received); King Edward VII Hospital London – Independent Contractor(Fees); University College Hospitals London – Employee (w-2 relationship)(Salary); University College London – Consultant (1099 relationship)(No Compensation Received), Investigator(No Compensation Received);
Philip R. Doiron, MD, FAAD
AbbVie – Advisory Board(Honoraria); Amgen – Advisory Board(Honoraria); Arcutis, Inc. – Advisory Board(Honoraria); Eli Lilly – Advisory Board(Honoraria); Galderma – Advisory Board(Honoraria); Incyte – Advisory Board(Honoraria); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria); Leo Pharma – Advisory Board(Honoraria); Organon – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Honoraria); Sanofi – Advisory Board(Honoraria); UCB – Advisory Board(Honoraria);
Georgios Kravvas, MBBS
No financial relationships exist with ineligible companies.